Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 55

1.

[Safety and efficacy of off-label use of biologic therapies in patients with inflammatory rheumatic diseases refractory to standard of care therapy : Data from a nationwide German registry (GRAID2)].

Proft F, Schulze-Koops H, Grunke M, Schrezenmeier E, Halleck F, Henes J, Unger L, Schmidt E, Fiehn C, Jacobi A, Iking-Konert C, Kneitz C, Schmidt RE, Bannert B, Voll RE, Fischer-Betz R, Kötter I, Tony HP, Holle J, Aringer M, Erler A, Behrens F, Burmester GR, Dörner T.

Z Rheumatol. 2017 Jun 6. doi: 10.1007/s00393-017-0330-4. [Epub ahead of print] German.

PMID:
28589389
2.

[Tapering and termination of immunosuppressive therapy : Systemic lupus erythematosus].

Aringer M, Leuchten N, Fischer-Betz R.

Z Rheumatol. 2017 Feb;76(1):27-32. doi: 10.1007/s00393-016-0258-0. Review. German.

PMID:
28097391
3.

Age-specific and sex-specific incidence of systemic lupus erythematosus: an estimate from cross-sectional claims data of 2.3 million people in the German statutory health insurance 2002.

Brinks R, Hoyer A, Weber S, Fischer-Betz R, Sander O, Richter JG, Chehab G, Schneider M.

Lupus Sci Med. 2016 Nov 25;3(1):e000181. eCollection 2016.

4.

A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS).

van Vollenhoven R, Voskuyl A, Bertsias G, Aranow C, Aringer M, Arnaud L, Askanase A, Balážová P, Bonfa E, Bootsma H, Boumpas D, Bruce I, Cervera R, Clarke A, Coney C, Costedoat-Chalumeau N, Czirják L, Derksen R, Doria A, Dörner T, Fischer-Betz R, Fritsch-Stork R, Gordon C, Graninger W, Györi N, Houssiau F, Isenberg D, Jacobsen S, Jayne D, Kuhn A, Le Guern V, Lerstrøm K, Levy R, Machado-Ribeiro F, Mariette X, Missaykeh J, Morand E, Mosca M, Inanc M, Navarra S, Neumann I, Olesinska M, Petri M, Rahman A, Rekvig OP, Rovensky J, Shoenfeld Y, Smolen J, Tincani A, Urowitz M, van Leeuw B, Vasconcelos C, Voss A, Werth VP, Zakharova H, Zoma A, Schneider M, Ward M.

Ann Rheum Dis. 2017 Mar;76(3):554-561. doi: 10.1136/annrheumdis-2016-209519. Epub 2016 Nov 24. Review.

PMID:
27884822
5.

Sequential high-content profiling of the IgG-autoantibody repertoire reveals novel antigens in rheumatoid arthritis.

Vordenbäumen S, Lueking A, Budde P, Zucht HD, Goehler H, Brinks R, Fischer-Betz R, Richter J, Bleck E, Detert J, Langer HE, Sörgel A, Burmester GR, Schulz-Knappe P, Schneider M.

Arthritis Res Ther. 2016 Oct 12;18(1):235.

6.

EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome.

Andreoli L, Bertsias GK, Agmon-Levin N, Brown S, Cervera R, Costedoat-Chalumeau N, Doria A, Fischer-Betz R, Forger F, Moraes-Fontes MF, Khamashta M, King J, Lojacono A, Marchiori F, Meroni PL, Mosca M, Motta M, Ostensen M, Pamfil C, Raio L, Schneider M, Svenungsson E, Tektonidou M, Yavuz S, Boumpas D, Tincani A.

Ann Rheum Dis. 2017 Mar;76(3):476-485. doi: 10.1136/annrheumdis-2016-209770. Epub 2016 Jul 25.

7.

Multiparametric detection of autoantibodies in systemic lupus erythematosus.

Budde P, Zucht HD, Vordenbäumen S, Goehler H, Fischer-Betz R, Gamer M, Marquart K, Rengers P, Richter J, Lueking A, Schulz-Knappe P, Schneider M.

Lupus. 2016 Jul;25(8):812-22. doi: 10.1177/0961203316641770.

PMID:
27252257
8.

[Standards of care for people with rheumatoid arthritis in Europe : Translation and comments of the eumusc.net recommendations supported by EULAR performed by a national task force of the professional organisations DGRh and VRA supported by "Deutsche Rheumaliga"].

Braun J, Krause A, Aringer M, Burmester G, Bessler F, Engel JM, Faubel U, Fischer-Betz R, Genth E, Gromnica-Ihle E, Hellmich B, Kötter I, Krüger K, Lakomek J, Lorenz HM, Manger B, Märker-Hermann E, Minden K, Müller-Ladner U, Rautenstrauch J, Rehart S, Riemekasten G, Rudwaleit M, Rüther W, Schett G, Schuch F, Schulze-Koops H, Specker C, Wassenberg S, Wiek D, Zink A, Schneider M.

Z Rheumatol. 2016 May;75(4):416-28. doi: 10.1007/s00393-016-0059-5. German.

PMID:
27138788
9.

The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation.

Götestam Skorpen C, Hoeltzenbein M, Tincani A, Fischer-Betz R, Elefant E, Chambers C, da Silva J, Nelson-Piercy C, Cetin I, Costedoat-Chalumeau N, Dolhain R, Förger F, Khamashta M, Ruiz-Irastorza G, Zink A, Vencovsky J, Cutolo M, Caeyers N, Zumbühl C, Østensen M.

Ann Rheum Dis. 2016 May;75(5):795-810. doi: 10.1136/annrheumdis-2015-208840. Epub 2016 Feb 17.

10.

Factors associated with pain coping and catastrophising in patients with systemic lupus erythematosus: a cross-sectional study of the LuLa-cohort.

Fischin J, Chehab G, Richter JG, Fischer-Betz R, Winkler-Rohlfing B, Willers R, Schneider M.

Lupus Sci Med. 2015 Nov 12;2(1):e000113. doi: 10.1136/lupus-2015-000113. eCollection 2015.

11.

[Lupus therapy on the move : The direction is right!].

Fischer-Betz R, Aringer M.

Z Rheumatol. 2015 Apr;74(3):182. doi: 10.1007/s00393-014-1455-3. German. No abstract available.

PMID:
25854150
12.

Validation and evaluation of the German version of the Systemic Lupus Activity Questionnaire (SLAQ).

Chehab G, Richter J, Sander O, Fischer-Betz R, Ostendorf B, Al-Neyadi T, Vordenbäumen S, Acar H, Brinks R, Schneider M.

Clin Exp Rheumatol. 2015 May-Jun;33(3):354-9. Epub 2015 Mar 10.

PMID:
25797042
13.

Lexis diagram and illness-death model: simulating populations in chronic disease epidemiology.

Brinks R, Landwehr S, Fischer-Betz R, Schneider M, Giani G.

PLoS One. 2014 Sep 12;9(9):e106043. doi: 10.1371/journal.pone.0106043. eCollection 2014.

14.

Age-specific prevalence of diagnosed systemic lupus erythematosus in Germany 2002 and projection to 2030.

Brinks R, Fischer-Betz R, Sander O, Richter JG, Chehab G, Schneider M.

Lupus. 2014 Nov;23(13):1407-11. doi: 10.1177/0961203314540352. Epub 2014 Jun 13.

PMID:
24928831
15.

[Early lupus erythematosus].

Fischer-Betz R, Schneider M.

Z Rheumatol. 2013 Dec;72(10):948-53. doi: 10.1007/s00393-013-1193-y. German.

PMID:
24337196
16.

Clinical outcomes and safety of rituximab treatment for patients with systemic lupus erythematosus (SLE) - results from a nationwide cohort in Germany (GRAID).

Witt M, Grunke M, Proft F, Baeuerle M, Aringer M, Burmester G, Chehab G, Fiehn C, Fischer-Betz R, Fleck M, Freivogel K, Haubitz M, Kötter I, Lovric S, Metzler C, Rubberth-Roth A, Schwarting A, Specker C, Tony HP, Unger L, Wassenberg S, Dörner T, Schulze-Koops H; German Registry of Autoimmune Diseases (GRAID) Investigators.

Lupus. 2013 Oct;22(11):1142-9. doi: 10.1177/0961203313503912.

PMID:
24057058
17.

[Pregnancy and inflammatory rheumatic diseases].

Fischer-Betz R, Späthling-Mestekemper S.

Z Rheumatol. 2013 Sep;72(7):669-82. doi: 10.1007/s00393-013-1223-9. German.

PMID:
23989692
18.

Validation and evaluation of the German Brief Index of Lupus Damage (BILD)--a self-reported instrument to record damage in systemic lupus erythematosus.

Chehab G, Sander O, Richter J, Acar H, Vordenbäumen S, Brinks R, Schneider M, Fischer-Betz R.

Lupus. 2013 Sep;22(10):1050-5. doi: 10.1177/0961203313500369.

PMID:
23963433
19.

[Rheumatic diseases in pregnancy].

Fischer-Betz R.

Dtsch Med Wochenschr. 2013 Aug;138(31-32):1589-91. doi: 10.1055/s-0033-1343257. Epub 2013 Jul 24. Review. German. No abstract available.

PMID:
23884745
20.

[Statement on the use of mycophenolate mofetil for systemic lupus erythematosus].

Aringer M, Fischer-Betz R, Hiepe F; Kommission Pharmakotherapie der DGRh; Germany Society of Rheumatology.

Z Rheumatol. 2013 Aug;72(6):575-80. doi: 10.1007/s00393-013-1213-y. German.

PMID:
23756593

Supplemental Content

Loading ...
Support Center